RESUMEN
BACKGROUND: Purpura and glomerulonephritis are typical presentations in IgA vasculitis. Infective endocarditis mimicking IgA vasculitis by presenting with glomerulonephritis and purpura is rarely reported. METHODS: We searched for cases with infective endocarditis-associated purpura and glomerulonephritis in a tertiary hospital in China and retrospectively reviewed their clinicopathological features. Differential diagnosis and treatment in patients with infective endocarditis-associated purpura and glomerulonephritis were discussed. RESULTS: A total of 20 cases with infective endocarditis-associated purpura and glomerulonephritis were identified among 548 cases with infective endocarditis in our center during an 8-year period: 7 of the 20 cases (35%) were initially misdiagnosed as IgA vasculitis and 10 cases (50%) presented with left-sided endocarditis caused by Streptococcus viridans. Fever (100%, 20 out of 20), prior valvular deformities (80%, 16 out of 20), cardiac murmur (95%, 19 out of 20), splenomegaly (84%, 16 out of 19), embolism (55%, 11 out of 20), and hypocomplementemia (76%, 13 out of 17) were present in most patients. Crescents and mesangial hypercellularity with or without endothelial hypercellularity were the primary findings on light microscopy, with C3-dominant deposition on immunofluorescence. But IgA-dominant staining was also observed (40%, 2 out of 5). In patients with rapidly progressive glomerulonephritis, patients with complete recovery of renal function had shorter disease duration and higher ratio (67% vs 20%) of immunosuppressive therapy compared with patients with partial recovery. CONCLUSIONS: Infective endocarditis-associated glomerulonephritis and purpura can closely mimic IgA vasculitis. Differential diagnosis is challenging, particularly when typical presentations of infective endocarditis are absent. In adults with presentations like IgA vasculitis, infective endocarditis should be evaluated through comprehensive clinical and pathological investigations. Immunosuppressive therapy can be considered in patients with severe glomerulonephritis who do not improve after proper anti-infective therapy.
Asunto(s)
Endocarditis/diagnóstico , Glomerulonefritis/fisiopatología , Vasculitis por IgA/diagnóstico , Púrpura/fisiopatología , Infecciones Estreptocócicas/diagnóstico , Adulto , Anticuerpos Anticitoplasma de Neutrófilos/sangre , Anticuerpos Antinucleares/sangre , Anticuerpos Antifosfolípidos/sangre , Autoanticuerpos/sangre , Proteínas del Sistema Complemento/metabolismo , Diagnóstico Diferencial , Endocarditis/sangre , Endocarditis/complicaciones , Endocarditis/fisiopatología , Femenino , Glomerulonefritis/sangre , Glomerulonefritis/etiología , Glomerulonefritis/patología , Humanos , Inmunosupresores/uso terapéutico , Masculino , Persona de Mediana Edad , Púrpura/sangre , Púrpura/etiología , Factor Reumatoide/sangre , Infecciones Estreptocócicas/sangre , Infecciones Estreptocócicas/complicaciones , Infecciones Estreptocócicas/fisiopatología , Trombocitopenia/sangre , Estreptococos Viridans , Adulto JovenAsunto(s)
COVID-19/complicaciones , Tiempo de Internación/estadística & datos numéricos , Úlcera por Presión/epidemiología , Púrpura/sangre , Centros Médicos Académicos , Adulto , Anciano , Femenino , Hospitales Urbanos , Humanos , Incidencia , Intubación Intratraqueal/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Úlcera por Presión/sangre , Úlcera por Presión/etiología , Posición Prona , Púrpura/virología , Estudios Retrospectivos , SARS-CoV-2Asunto(s)
Vacunas contra la COVID-19/efectos adversos , COVID-19/prevención & control , Trombocitopenia/etiología , Vacuna nCoV-2019 mRNA-1273 , Adulto , Analgésicos no Narcóticos/uso terapéutico , Vacunas contra la COVID-19/uso terapéutico , Enfermedad Crónica , Dexametasona/uso terapéutico , Femenino , Glucocorticoides/uso terapéutico , Cefalea/sangre , Cefalea/tratamiento farmacológico , Cefalea/etiología , Humanos , Ibuprofeno/uso terapéutico , Inmunoglobulinas Intravenosas/uso terapéutico , Recuento de Plaquetas , Púrpura/sangre , Púrpura/tratamiento farmacológico , Púrpura/etiología , Trombocitopenia/sangre , Trombocitopenia/tratamiento farmacológicoAsunto(s)
Acrodermatitis/diagnóstico , Betacoronavirus/aislamiento & purificación , Infecciones por Coronavirus/diagnóstico , Neumonía Viral/diagnóstico , Púrpura/diagnóstico , Acrodermatitis/sangre , Acrodermatitis/etiología , Acrodermatitis/patología , Adolescente , Betacoronavirus/patogenicidad , Biopsia , COVID-19 , Prueba de COVID-19 , Técnicas de Laboratorio Clínico , Infecciones por Coronavirus/sangre , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/virología , Diagnóstico Diferencial , Humanos , Masculino , Pandemias , Neumonía Viral/sangre , Neumonía Viral/epidemiología , Neumonía Viral/virología , Tiempo de Protrombina , Púrpura/sangre , Púrpura/complicaciones , Púrpura/patología , SARS-CoV-2 , Piel/patologíaAsunto(s)
Enfermedades de la Mama , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas , Púrpura , Anciano de 80 o más Años , Enfermedades de la Mama/sangre , Enfermedades de la Mama/diagnóstico , Femenino , Humanos , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas/sangre , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas/diagnóstico , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas/patología , Púrpura/sangre , Púrpura/diagnóstico , Púrpura/patologíaAsunto(s)
Deficiencia de Almacenamiento del Pool Plaquetario , Púrpura , Enfermedades de la Piel , Niño , Femenino , Humanos , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/diagnóstico , Deficiencia de Almacenamiento del Pool Plaquetario/patología , Púrpura/sangre , Púrpura/diagnóstico , Púrpura/patología , Enfermedades de la Piel/sangre , Enfermedades de la Piel/diagnóstico , Enfermedades de la Piel/patologíaRESUMEN
BACKGROUND: Anti-nuclear antibodies (ANA), anti-extractable nuclear antigens (ENA) and anti-dsDNA antibodies are often associated with cutaneous lupus erythematosus (CLE), with variable frequency depending on skin subtype. However, specific data based on large case-series on the pathogenetic, diagnostic and prognostic meaning of such autoantibodies are still lacking. OBJECTIVE: To characterize the correlations between CLE subtypes as well as LE-non-specific skin lesions and their autoantibody pattern. METHODS: Epidemiological, clinical and immunopathological data of 619 Italian patients with CLE and LE-non-specific skin lesions were analysed. Differences in age, sex, clinical features and autoantibody profile were evaluated in each LE subgroup. RESULTS: Anti-nuclear antibodies (P < 0.0001), anti-dsDNA (P < 0.0001), ENA (P = 0.001), anti-Sm (P = 0.001), anti-RNP (P = 0.004) and anti-histone (P = 0.005) antibodies were associated with SLE. A strong association between ANA (P < 0.0001) and anti-dsDNA (P < 0.0001) and female gender was also found: positive ANA and positive anti-dsDNA had a higher prevalence among females. Chronic CLE resulted to be negatively associated with ENA (OR = 0.51, P < 0.0001), anti-Ro/SSA (OR = 0.49, P < 0.0001) and anti-dsDNA (OR = 0.37, P < 0.0001). Intermittent CLE resulted to be negatively associated with ENA (OR = 0.50, P = 0.007) and ANA (OR = 0.61, P = 0.025). Subacute CLE resulted to be associated with ENA (OR = 5.19, P < 0.0001), anti-Ro/SSA (OR = 3.83, P < 0.0001), anti-Smith (OR = 2.95, P = 0.004) and anti-RNP (OR = 3.18, P = 0.007). Acute CLE resulted to be strongly associated with anti-dsDNA (OR = 6.0, P < 0.0001) and ANA (OR = 18.1, P < 0.0001). LE-non-specific skin lesions resulted to be significantly associated with systemic involvement. Livedo reticularis was significantly associated with ENA (P = 0.007) and anti-Ro/SSA (P = 0.036). Palpable purpura and periungual telangiectasia were significantly associated with ANA. CONCLUSION: According to our findings, some well-known associations between CLE subtypes and autoantibody profile were confirmed; moreover, specific association between autoantibodies and LE-non-specific skin lesions was highlighted. A strict association between anti-ENA and anti-Ro/SSA antibodies and livedo reticularis, ANA and palpable purpura, and ANA and periungual telangiectasia was evidenced.
Asunto(s)
Anticuerpos Antinucleares/sangre , Lupus Eritematoso Cutáneo/sangre , Lupus Eritematoso Cutáneo/epidemiología , Enfermedad Aguda , Adulto , Antígenos Nucleares/inmunología , Autoantígenos/inmunología , Enfermedad Crónica , Estudios Transversales , ADN/inmunología , Femenino , Histonas/inmunología , Humanos , Italia/epidemiología , Livedo Reticularis/sangre , Livedo Reticularis/epidemiología , Masculino , Persona de Mediana Edad , Púrpura/sangre , Púrpura/epidemiología , ARN Citoplasmático Pequeño/inmunología , Ribonucleoproteínas/inmunología , Factores Sexuales , Telangiectasia/sangre , Telangiectasia/epidemiologíaRESUMEN
An acquired, transient bleeding disorder that predominantly affects children in Southeast Asia has been reported for the last 4 decades. The condition has been named idiopathic purpura with gray platelets (IPGP) or acquired platelet dysfunction with eosinophilia. In a retrospective review from a private pediatric clinic over an 8-year period, 10 consecutive children were diagnosed as IPGP with a mean age of 8.4 (3.7 to 16.2) years. Eosinophilia (>0.5×10/L) was absent in 1, while gray platelets were consistently found in all cases with a mean proportion of 64.5% (40% to 80%). Platelet aggregation tests were performed in 9 patients with abnormal responses consistent with platelet storage pool defect. All children recovered completely and spontaneously from 1 to 4 months after diagnosis without specific therapy. In an otherwise well child who presents abruptly with easy bruising and a platelet count >100×10/L, IPGP can be readily recognized as an acquired form of gray platelet syndrome. Eosinophilia is common but not mandatory for diagnosis.
Asunto(s)
Plaquetas/metabolismo , Síndrome de Plaquetas Grises/sangre , Agregación Plaquetaria , Púrpura/sangre , Adolescente , Plaquetas/patología , Niño , Preescolar , Eosinofilia/sangre , Eosinofilia/patología , Femenino , Síndrome de Plaquetas Grises/patología , Humanos , Masculino , Pruebas de Función Placentaria , Recuento de Plaquetas , Púrpura/patología , Remisión Espontánea , Estudios RetrospectivosRESUMEN
OBJECTIVE: To delineate the clinical and genetic characteristics of a girl featuring motor retardation, language retardation and regression, and light persisting diarrhea. METHODS: The patient was clinically examined and tested by tandem mass spectrometry and next generation sequencing. RESULTS: The proband could not stand and walk alone, and had light persisting diarrhea. She manifested language development retardation and regression. Laboratory tests were all normal, but the screening of metabolic disorders for urine and blood showed deficiency of short chain coenzyme A dehydrogenase due to elevated ethylmalonic acid and butyryl carnitine. By next generation sequencing, two compound heterozygous mutations of the ETHE1 gene, c.2T>A and c.488G>A, were discovered in the proband, which were respectively inherited from her father and mother. Bioinformatics analysis predicted both mutations to be pathogenic. The patient was diagnosed with ethylmalonic encephalopathy. Vitamin B1, B2, Coenzyme Q10, and L-carnitine were prescribed. The patient deteriorated and required liver transplantation at 4-year-1-month. CONCLUSION: Based on the clinical and genetic analysis, the proband was diagnosed with ethylmalonic encephalopathy caused by ETHE1 gene mutation. Next generation sequencing has provided a powerful tool for the diagnosis of such disorders.
Asunto(s)
Encefalopatías Metabólicas Innatas/genética , Púrpura/genética , Encefalopatías Metabólicas Innatas/sangre , Carnitina/sangre , Preescolar , Femenino , Pruebas Genéticas , Humanos , Malonatos/sangre , Proteínas Mitocondriales/genética , Proteínas de Transporte Nucleocitoplasmático/genética , Mutación Puntual , Púrpura/sangreRESUMEN
BACKGROUND: While different clinical manifestations of IgM and IgG monoclonal cryoglobulins have been demonstrated, little is known about the roles of IgG subclasses in the pathophysiology of these conditions. METHODS: In two cases of myeloma-associated monoclonal (type I) cryoglobulinemia with quite distinct clinical and biological features, serum samples were analyzed using an original IgG subclass-specific immunoblotting technique. RESULTS: The first case had painful arthritis of hands and feet, with skin purpura and a sharp decrease of complement C4 level, and the cryoglobulin was of IgG1 subclass. The second case displayed mostly thrombotic lesions of the limb extremities, C3 and C4 serum levels were normal, and the cryoglobulin belonged to the IgG2 subclass. CONCLUSIONS: Type I cryoglobulins of distinct IgG subclasses may result in different syndromes. In both cases, the treatment relies on eradication of the underlying plasma cell dyscrasia.
Asunto(s)
Crioglobulinas/metabolismo , Inmunoglobulina G/sangre , Mieloma Múltiple/sangre , Paraproteinemias/terapia , Anciano de 80 o más Años , Complemento C4/inmunología , Complemento C4/metabolismo , Crioglobulinas/inmunología , Resultado Fatal , Femenino , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina M/sangre , Inmunoglobulina M/inmunología , Persona de Mediana Edad , Mieloma Múltiple/diagnóstico , Mieloma Múltiple/inmunología , Paraproteinemias/diagnóstico , Paraproteinemias/inmunología , Púrpura/sangre , Púrpura/inmunologíaRESUMEN
A two-month-old boy visited the hospital due to unexpected cutaneous purpura and thrombocytopenia for 2 days. The physical examination revealed a purple mass on the back. The soft tissue color Doppler ultrasound showed rich blood signals in the tissue, and the results of bone marrow puncture indicated an increased number of megakaryocytes. After the treatment with hormone and gamma globulin, the platelet count rapidly increased and maintained at a normal level. Meanwhile, the boy was given oral administration of propranolol. He was followed up for 4 months and the volume of the mass on the back was reduced significantly. He had a definite diagnosis of hemangioma and immune thrombocytopenia. As for the patients with hemangioma complicated by thrombocytopenia, knowledge of Kasabach-Merritt syndrome should be enhanced and there should be a clarification of the association between thrombocytopenia and hemangioma. There should also be an alertness for thrombocytopenia of other causes.
Asunto(s)
Púrpura/tratamiento farmacológico , Púrpura/etiología , Humanos , Lactante , Masculino , Recuento de Plaquetas , Púrpura/sangre , Trombocitopenia/etiologíaRESUMEN
BACKGROUND: It is unusual for purpura to emerge as a result of drinking alcohol. Such a peculiarity was observed in a 55-year-old man with a 30-year history of heavy alcohol use. CASE PRESENTATION: The Caucasian patient was studied for 11 years during several detoxification treatments. During the last 2 years of that period, purpuric rashes were newly observed. The asymptomatic purpura was limited to both lower limbs, self-limiting with abstinence, and reoccurring swiftly with alcohol relapse. This sequence was observed six times, suggesting a causative role of alcohol or its metabolites. A skin biopsy revealed histological features of purpura pigmentosa progressiva (termed Schamberg's disease). Additionally, alcoholic fatty liver disease markedly elevated serum immunoglobulins (immunoglobulin A and immunoglobulin E), activated T-lymphocytes, and increased C-reactive protein. In addition, moderate combined (cellular and humoral) immunodeficiency was found. Unlike the patient's immunoglobulin A level, his serum immunoglobulin E level fell in the first days of abstinence, which corresponded to the time of purpura decline. Systemic vasculitis and clotting disorders were excluded. The benign character of the purpura was supported by missing circulating immune complexes or complement activation. An alcohol provocation test with vinegar was followed by the development of fresh "cayenne pepper" spots characteristic of Schamberg's disease. CONCLUSIONS: This case report demonstrates that Schamberg's disease can be strongly related to alcohol intake, in our patient most likely as a late complication of severe alcoholism with alcoholic liver disease. Immunologic disturbances thereby acquired could have constituted a basis for a hypersensitivity-like reaction after ingestion of alcohol. Schamberg's disease induction by vinegar may point to an involvement of acetate, a metabolite of ethanol.
Asunto(s)
Trastornos Relacionados con Alcohol/complicaciones , Inmunoglobulinas/sangre , Trastornos de la Pigmentación/sangre , Trastornos de la Pigmentación/etiología , Púrpura/sangre , Púrpura/etiología , Trastornos Relacionados con Alcohol/sangre , Humanos , Masculino , Persona de Mediana Edad , RecurrenciaAsunto(s)
Púrpura/diagnóstico , Púrpura/etiología , Corticoesteroides/uso terapéutico , Anciano , Diagnóstico Diferencial , Femenino , Humanos , Inmunoglobulinas Intravenosas , Recuento de Plaquetas , Transfusión de Plaquetas , Complicaciones Posoperatorias , Púrpura/sangre , Púrpura/tratamiento farmacológico , Púrpura Trombocitopénica/diagnóstico , Reacción a la TransfusiónRESUMEN
The aim of the study was to investigate the association between capillary fragility and some hemostatic parameters, lipid profile in patients with rosacea. 50 patients (30 women and 20 men) aged 35 to 65 years were under observation. Control group consisted of 50 healthy persons, adequate to comparison group by sex and age. To determine the resistance of the capillary, Rumpel-Leede cuff (tourniquet test) was used which consists in determining the formation of petechial hemorrhages on the skin in the area of ââshort-term increase in venous pressure. The hemostatic system was evaluated in terms of prothrombin and thrombin time. Content of fibrinogen and fibrinolytic activity of blood were determined also. The serum lipid profile was studied by means of the following parameters: total cholesterol, triglycerides, HDL (high density lipoprotein), LDL (low density lipoproteins). The survey revealed that in 25 patients the arm cuff test was positive, whereas in the control group, only 2 cases it was weakly positive. Manifestations of hypercoagulation were found in half of patients with a positive cuff test, almost in half of the patients an increased level of fibrinogen and the reduced fibrinolytic activity in blood serum has been revealed. Significant correlation with lipid metabolism have not been identified. Phenomenon of hypercoagulation in rosacea patients on the one hand suggests the existence of processes of microcoagulation, on the other hand the connection with the results of a cuff test can be used to predict the severity of the dermatosis and the possible risk for developing of cardiovascular disease.
Asunto(s)
Fragilidad Capilar , Lípidos/sangre , Púrpura/sangre , Rosácea/sangre , Adulto , Anciano , Colesterol/sangre , LDL-Colesterol/sangre , Femenino , Hemorragia/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Tiempo de Protrombina , Púrpura/fisiopatología , Rosácea/complicaciones , Rosácea/fisiopatología , Tiempo de Trombina , Triglicéridos/sangreAsunto(s)
Quimiocina CCL17/sangre , Citocinas/análisis , Trastornos de la Pigmentación/sangre , Púrpura/sangre , Biomarcadores/análisis , Biomarcadores/sangre , Epidermis/química , Humanos , Masculino , Persona de Mediana Edad , Trastornos de la Pigmentación/patología , Púrpura/patología , Linfopoyetina del Estroma TímicoRESUMEN
Pigmented purpuric dermatosis (PPD) is characterized by petechial and pigmented macules on the lower limbs. The aetiology of PPD remains obscure. Some reports have suggested an association between PPD and hepatitis B or C infection. This prospective case-control study was designed to investigate the association of positive hepatitis B or C serology with PPD. A total of 60 PPD patients and 230 randomly selected controls were enrolled. Sera from all patients and controls were tested for liver function tests (LFT), hepatitis B surface antigen (HBS Ag), and hepatitis C virus antibody (HCV Ab). The prevalence of HBS Ag in patients with PPD and the controls was 3 per cent (5/60) and 4.3 per cent (10/230), respectively. The prevalence of HCV Ab was 1.7 per cent (1/60) and 1.3 per cent (3/230) among patients and controls, respectively. No statistically significant difference was noted in the prevalence of positive hepatitis B or C serology (P-values 0.73 and 0.58, respectively). No statistically significant difference in LFT was observed between the two groups. Therefore, the authors believe it is unlikely that HBV or HCV are directly involved in the pathogenesis of PPD.
Asunto(s)
Hepatitis B/epidemiología , Hepatitis C/epidemiología , Trastornos de la Pigmentación/epidemiología , Púrpura/epidemiología , Adulto , Estudios de Casos y Controles , Femenino , Hepacivirus/inmunología , Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/sangre , Hepatitis C/sangre , Anticuerpos contra la Hepatitis C/sangre , Humanos , Irán/epidemiología , Pruebas de Función Hepática , Masculino , Persona de Mediana Edad , Trastornos de la Pigmentación/sangre , Estudios Prospectivos , Púrpura/sangre , Estudios Seroepidemiológicos , Pruebas SerológicasRESUMEN
Pediatric scurvy is a rare condition characterized by perifollicular petechiae and bruising, hemorrhagic gingivitis and musculoskeletal symptoms, all assumed to be predominantly related to abnormal collagen structure. We report on a 9-year-old autistic boy with vitamin C deficiency due to a highly limited food range presenting with multiple petechiae, gum bleeding and debilitating bone pain, in whom platelet aggregometry revealed a distinctly reduced thrombocyte aggregation, normalizing after vitamin C supplementation. This observation indicates that platelet dysfunction may additionally contribute to the hemorrhagic diathesis in scurvy, and demonstrates that ascorbic acid deficiency should be considered in children with an otherwise unexplained acquired thrombocytopathy.